DNV Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Investments
-
37
- Portfolio
-
17
- Exits
-
19

DNV Capital General Information
Company Description
DiNova Venture Capital global venture capital firm. The company focuses on medical industries. It specializes in medical treatment particularly medical equipment and services. It seeks to make early to growth stage investments in high-end medical technology and E-health. As of May 2015, Dinova Capital has invested 13 deals in Europe and America, 3 deals in China. The company is headquartered in Shenzhen, China.
Business Details
Website
www.dnvcapital.comYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- Suite 230 Changhong Tech Building, Keji South Road
- Nanshan District
- Shenzhen, Guangdong 518000
- China
DNV Capital Investments (37)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Sinovation | 28-Jun-2023 | Later Stage VC | Surgical Devices | Generating Revenue | ||
T-Ray Technology | 01-May-2023 | Connectivity Products | Generating Revenue | |||
SHURUI | 23-Mar-2023 | Surgical Devices | Generating Revenue | |||
PINS Medical | 03-Jan-2023 | Therapeutic Devices | Generating Revenue | |||
Direct Flow Medical | 10-Aug-2022 | Surgical Devices | Profitable | |||
Binhui Biopharm | 28-Mar-2022 | Biotechnology | Generating Revenue | |||
Shanghai Outai | 01-Jan-2022 | Surgical Devices | Generating Revenue | |||
Xuanzhu Biopharm | 31-Dec-2021 | Drug Discovery | Clinical Trials - General | |||
Metronom Health | 23-Dec-2020 | Later Stage VC | Monitoring Equipment | Generating Revenue | ||
Cyrano Therapeutics | 04-Nov-2020 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 |
DNV Capital Exits (19)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Xuanzhu Biopharm | 15-Nov-2024 | Secondary Transaction - Private | |
Hinova Pharmaceuticals | 12-Apr-2022 | ||
CANbridge Pharma | 10-Dec-2021 | ||
Sonendo | 29-Oct-2021 | ||
Broncus Medical | 13-Sep-2021 | ||
Human Xtensions | 01-Dec-2020 | ||
Venus Medtech | 10-Dec-2019 | ||
Sorrento Therapeutics | 28-Jun-2019 | ||
Mitralign | 12-Mar-2019 | Merger/Acquisition | |
LoneStar Heart | 01-Jul-2018 | Out of Business |
DNV Capital Investments by Industry, Year, and Region
DNV Capital Co-Investors (28)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Haier Capital | 1 |
![]() |
![]() |
||
Hubei High-tech Industrial Investment Group |
![]() |
![]() |
|||
Legend Capital |
![]() |
![]() |
|||
Sunshine Insurance Group |
![]() |
![]() |
|||
Suzhou Guofa Venture Capital |
![]() |
![]() |
DNV Capital FAQs
-
What is DNV Capital?
DiNova Venture Capital global venture capital firm.
-
When was DNV Capital founded?
DNV Capital was founded in 2011.
-
Where is DNV Capital headquartered?
DNV Capital is headquartered in Shenzhen, China.
-
What is DNV Capital's total asset value?
DNV Capital has around
in total assets under management. -
How many investments has DNV Capital made?
DNV Capital has made 37 investments.
-
What has DNV Capital invested in?
DNV Capital has made numerous investments in companies like Sinovation, T-Ray Technology, and SHURUI within the Surgical Devices and Connectivity Products industries.
-
What has DNV Capital invested in recently?
DNV Capital's latest investment was on 28-Jun-2023 in Sinovation, a company within the Surgical Devices industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »